Written answers
Thursday, 28 January 2021
Department of Health
Medicinal Products
Ruairí Ó Murchú (Louth, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
267. To ask the Minister for Health when the HSE executive management team will consider the recommendations and decide on the approval for reimbursement of the drug dupilumab; and if he will make a statement on the matter. [4802/21]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments